The Selux PBC Separator, part of the Next Generation Phenotyping (NGP) System, makes this the only FDA cleared, single-platform technology capable of delivering rapid AST results for both positive blood culture and isolated colonies.

Former President of BD North America brings global healthcare leadership experience as Selux launches its recently FDA-cleared NGP System for rapid antibiotic susceptibility testing.

In vitro antimicrobial resistance test enables clinical labs to deliver targeted therapeutic results days faster than the current standard of care, clearing the path for personalized antibiotic therapies

World Textile Information Network winners announced in Frankfurt, Germany

Hygienics launches the first of a range of products that will bring cost effective and hospital quality infection control to a wider market.

This treatment is based upon a synergistic combination of an antibiotic plus a cortisol modulator that would add to the strength of the antibiotic, a more vigorous response by the patient's own immune system.